| SEFIDENCE Fulcrum Therapeutics, Inc.
98437143 06 Mar 2024 | on 12 Nov 2024 | Pharmaceutical preparations for treatment of muscle disease including,... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for treatment of muscle disease including, but not limited to, Facioscapulohumeral Muscular Dystrophy/Atrophy Class 042 Class 042 Computer & Software Services & Scientific Services Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals Class 044 Medical, Beauty & Agricultural Services Clinical research in the field of Facioscapulohumeral Muscular Dystrophy/Atrophy; Testing, inspection, research, or development of pharmaceutical preparations for treatment of Facioscapulohumeral Muscular Dystrophy/Atrophy; Pharmaceutical products development; Development of pharmaceutical preparations and medicines | | | FSHD REACH Fulcrum Therapeutics, Inc.
97292306 02 Mar 2022 | on 06 Sep 2024 | Providing information relating to diagnostic, prophylactic and therape... Class 042 Class 042 Computer & Software Services & Scientific Services Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals Class 044 Class 044 Medical, Beauty & Agricultural Services "FSHD" | | | RISE Fulcrum Therapeutics, Inc.
97304026 09 Mar 2022 | on 06 Sep 2024 | Providing information relating to diagnostic, prophylactic and therape... Class 042 Class 042 Computer & Software Services & Scientific Services The mark consists of the word "RISE" in all capital letters, which is bordered on the outside by a rectangular box, and a small crescent shape on the inside of the right curve of the letter "R". Class 044 Class 044 Medical, Beauty & Agricultural Services Color is not claimed as a feature of the mark. | | | FYSMOVY Fulcrum Therapeutics, Inc.
97388495 29 Apr 2022 | on 06 Sep 2024 | Pharmaceutical preparations for treatment of muscle disease including,... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for treatment of muscle disease including, but not limited to, Facioscapulohumeral Muscular Dystrophy/Atrophy | | | FYSMOVDY Fulcrum Therapeutics, Inc.
97388503 29 Apr 2022 | on 09 Jul 2024 | Pharmaceutical preparations for treatment of muscle disease including,... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for treatment of muscle disease including, but not limited to, Facioscapulohumeral Muscular Dystrophy/Atrophy | | | FAZMYO Fulcrum Therapeutics, Inc.
97388509 29 Apr 2022 | on 09 Jul 2024 | Pharmaceutical preparations for treatment of muscle disease including,... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for treatment of muscle disease including, but not limited to, Facioscapulohumeral Muscular Dystrophy/Atrophy | | | REACH Fulcrum Therapeutics, Inc.
97292298 02 Mar 2022 | on 01 May 2024 | Clinical research in the field of Facioscapulohumeral Muscular Dystrop... Class 042 Class 042 Computer & Software Services & Scientific Services Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals Class 044 Class 044 Medical, Beauty & Agricultural Services Clinical research in the field of Facioscapulohumeral Muscular Dystrophy/Atrophy; Testing, inspection, research, or development of pharmaceutical preparations for treatment of Facioscapulohumeral Muscular Dystrophy/Atrophy; Pharmaceutical products development; Development of pharmaceutical preparations and medicines | | | REACH Fulcrum Therapeutics, Inc.
97359714 12 Apr 2022 | on 01 May 2024 | Clinical research in the field of Facioscapulohumeral Muscular Dystrop... Class 042 Class 042 Computer & Software Services & Scientific Services Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals Class 044 Class 044 Medical, Beauty & Agricultural Services Clinical research in the field of Facioscapulohumeral Muscular Dystrophy/Atrophy; Testing, inspection, research, or development of pharmaceutical preparations for treatment of Facioscapulohumeral Muscular Dystrophy/Atrophy; Pharmaceutical products development; Development of pharmaceutical preparations and medicines | | | EMRUKYO Fulcrum Therapeutics, Inc.
97629045 12 Oct 2022 | on 16 Jan 2024 | Pharmaceutical preparations for treatment of muscle disease including,... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for treatment of muscle disease including, but not limited to, Facioscapulohumeral Muscular Dystrophy/Atrophy | | | OMMOVY Fulcrum Therapeutics, Inc.
97388474 29 Apr 2022 | on 16 Jan 2024 | Pharmaceutical preparations for treatment of muscle disease including,... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for treatment of muscle disease including, but not limited to, Facioscapulohumeral Muscular Dystrophy/Atrophy | | 
